More on VYGR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+10.6% Growth)
- Ratings (7.7 Score)
- Holders

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Voyager Therapeutics (NQ:VYGR)
Delayed: 1.90 -0.16 (7.77%)
Prev. Close $2.06  
Open$2.05 
52 Wk High$30.54 
52 Wk Low$8.12 
Day High$2.05 
Day Low$1.89 
P/E N/A  
EPS$0.00 
Volume573,204 

Friends, Peers and Foes (?): BNTX, GSK, MRNA, PFE, SLDB (more...)

Aug 27, 2026 07:08 AM H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)
Aug 14, 2026 10:30 AM Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Aug 6, 2026 05:34 PM Voyager Therapeutics (VYGR) Tops Q2 EPS by 10c
Aug 6, 2026 04:04 PM Form 8-K Voyager Therapeutics, For: Aug 06
Aug 6, 2026 04:03 PM Form 10-Q Voyager Therapeutics, For: Jun 30
Aug 6, 2026 04:01 PM Voyager Reports Second Quarter 2026 Financial and Operating Results
Jul 31, 2026 06:15 PM Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Jul 20, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR)
Jul 13, 2026 08:44 AM Form 8-K Voyager Therapeutics, For: Jul 13
Jul 13, 2026 08:04 AM Voyager tau gene therapy shows tolerability in 6-month NHP study
View All Articles

Entities mentioned with VYGR

View All Entities